Baxter International Inc. (NYSE:BAX – Get Free Report) declared a quarterly dividend on Tuesday, July 16th, RTT News reports. Stockholders of record on Friday, August 30th will be paid a dividend of 0.29 per share by the medical instruments supplier on Tuesday, October 1st. This represents a $1.16 annualized dividend and a dividend yield of 3.07%. The ex-dividend date is Friday, August 30th.
Baxter International has raised its dividend payment by an average of 6.7% per year over the last three years. Baxter International has a payout ratio of 37.5% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Baxter International to earn $3.18 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 36.5%.
Baxter International Price Performance
Shares of NYSE BAX opened at $37.82 on Thursday. Baxter International has a fifty-two week low of $31.01 and a fifty-two week high of $44.01. The stock has a market capitalization of $19.27 billion, a price-to-earnings ratio of 7.27, a PEG ratio of 1.88 and a beta of 0.57. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.48 and a quick ratio of 1.01. The business has a 50-day moving average of $35.26 and a 200-day moving average of $37.67.
Analysts Set New Price Targets
A number of equities analysts have commented on the stock. StockNews.com raised shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. TD Cowen downgraded Baxter International from a “buy” rating to a “hold” rating and set a $40.00 target price on the stock. in a research report on Friday, May 10th. Wells Fargo & Company reduced their price target on Baxter International from $44.00 to $40.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 7th. Citigroup dropped their target price on Baxter International from $38.00 to $37.00 and set a “neutral” rating for the company in a report on Wednesday, July 10th. Finally, Evercore ISI decreased their price target on shares of Baxter International from $46.00 to $45.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $41.73.
Get Our Latest Stock Report on Baxter International
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
See Also
- Five stocks we like better than Baxter International
- How to Evaluate a Stock Before BuyingÂ
- Bath & Body Works Rebound Ahead? Why Analysts Remain Optimistic
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Stocks to Watch as the Dollar Declines to a 7-Month Low
- Where to Find Earnings Call Transcripts
- MGM Insiders Bet Big on Its Undervalued Stock
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.